Anti-idiotype antibody generation and application in antibody drug discovery

Are you developing antibody drugs? Have you considered generating anti-idiotype antibodies (anti-IDs)? Anti-IDs recognize the region unique to your antibody drug, the complementarity determining region (CDR), making them useful in pharmacokinetic (PK) and pharmacodynamic (PD) studies to specifically measure circulating antibody drug concentrations. They also serve as positive controls or reference standards in immune response (IR) assays. Join this interactive webinar to learn about the different types of anti-IDs and their use in PK/PD and immunogenicity assays. We will review the obstacles and solutions surrounding the generation of highly sensitive, highly specific anti-IDs with examples from vaccine and antibody drug development case studies.

Speaker-related Webinars

Introduction to immune checkpoints – the new hot target for cancer immunotherapy

Development of therapeutic antibodies against immune checkpoints for the treatment of melanoma and other cancers is gaining momentum among academia and the pharmaceutical industry.

Learn More

Leveraging GenScript’s cytokines, antibodies, and protein purification tools to explore Ideas for your next grant

Wouldn't it be great if all the supplies you needed to obtain preliminary data for your next grant were available from the same vendor? This webinar will show you how to incorporate

Learn More

Recombinant protein applications: choosing the best cytokine, growth factor or chemokine for your experimental system

Are you treating cells in vitro? Do your in vivo studies investigate changes in the immune response or tumor growth?

Learn More

Stem cell culture: choosing the best conditions for optimal expansion and differentiation

Are you finding your rate of stem cell differentiation to be less than optimal? Choosing the appropriate conditions for stem cell expansion and differentiation is critical for obtaining a high yield of properly differentiated cells

Learn More

Biologics Drug Discovery: Steps to Achieving an Antibody Drug Candidate

In the past decade, drug discovery has focused on developing biologics. In particular, antibody therapeutics have been proven to be clinically effective for disease areas such as oncology and immunology.

Learn More